Cancer Detection from Plasma Cell-Free DNA
Liquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-cancer detection in a non-invasive way. The whole-genome bisulfite sequencing (WGBS) is widely used in cfDNA sequencing analysis and lays the foundation for further study on cfDNA. The cfDNA released b...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2020-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2020/78/e3sconf_iseese2020_03049.pdf |
id |
doaj-5de8eafff185476789e8f162de5ce050 |
---|---|
record_format |
Article |
spelling |
doaj-5de8eafff185476789e8f162de5ce0502021-04-02T16:33:17ZengEDP SciencesE3S Web of Conferences2267-12422020-01-012180304910.1051/e3sconf/202021803049e3sconf_iseese2020_03049Cancer Detection from Plasma Cell-Free DNAChen Li0Department of Biomedical Engineering, Engineering College, Peking UniversityLiquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-cancer detection in a non-invasive way. The whole-genome bisulfite sequencing (WGBS) is widely used in cfDNA sequencing analysis and lays the foundation for further study on cfDNA. The cfDNA released by multiple tissues carries genetic and epigenetic information. Methylation patterns, copy number variation (CNV) and fragmentation changes have been discovered in previous studies and achieved a promising accuracy. In this review, different cancer detection methods based on these three biomarkers are introduced. In addition, feature fusion is discussed for its potential in enhancing performance in clinical applications.https://www.e3s-conferences.org/articles/e3sconf/pdf/2020/78/e3sconf_iseese2020_03049.pdf |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chen Li |
spellingShingle |
Chen Li Cancer Detection from Plasma Cell-Free DNA E3S Web of Conferences |
author_facet |
Chen Li |
author_sort |
Chen Li |
title |
Cancer Detection from Plasma Cell-Free DNA |
title_short |
Cancer Detection from Plasma Cell-Free DNA |
title_full |
Cancer Detection from Plasma Cell-Free DNA |
title_fullStr |
Cancer Detection from Plasma Cell-Free DNA |
title_full_unstemmed |
Cancer Detection from Plasma Cell-Free DNA |
title_sort |
cancer detection from plasma cell-free dna |
publisher |
EDP Sciences |
series |
E3S Web of Conferences |
issn |
2267-1242 |
publishDate |
2020-01-01 |
description |
Liquid biopsy of cell-free DNA (cfDNA) has attracted much attention for its promise to realize pan-cancer detection in a non-invasive way. The whole-genome bisulfite sequencing (WGBS) is widely used in cfDNA sequencing analysis and lays the foundation for further study on cfDNA. The cfDNA released by multiple tissues carries genetic and epigenetic information. Methylation patterns, copy number variation (CNV) and fragmentation changes have been discovered in previous studies and achieved a promising accuracy. In this review, different cancer detection methods based on these three biomarkers are introduced. In addition, feature fusion is discussed for its potential in enhancing performance in clinical applications. |
url |
https://www.e3s-conferences.org/articles/e3sconf/pdf/2020/78/e3sconf_iseese2020_03049.pdf |
work_keys_str_mv |
AT chenli cancerdetectionfromplasmacellfreedna |
_version_ |
1721556255996116992 |